Beyond Spirometry: Linking Wasted Ventilation to Exertional Dyspnea in the Initial Stages of COPD

References

• O’Donnell DE, Milne KM, James MD, et al. Dyspnea in COPD: new mechanistic insights and management implications. Adv Ther. 2020;37(1):1–11. doi:10.1007/s12325-019-01128-9.
   Web of Science ®Google Scholar
• Tan WC, Sin DD, Bourbeau J, et al. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study. Thorax. 2015;70(9):822–829. doi:10.1136/thoraxjnl-2015-206938.
   PubMed Web of Science ®Google Scholar
• Tan WC, Hague CJ, Leipsic J, et al. Findings on thoracic computed tomography scans and respiratory outcomes in persons with and without chronic obstructive pulmonary disease: a Population-Based cohort study. PLoS ONE. 2016;11(11):e0166745. doi:10.1371/journal.pone.0166745.
   PubMed Web of Science ®Google Scholar
• Cherian M, Jensen D, Tan WC, et al. Dyspnoea and symptom burden in mild-moderate COPD: the Canadian cohort obstructive lung disease study. ERJ Open Res. 2021;7(2):00960–2020. doi:10.1183/23120541.00960-2020.
   PubMedGoogle Scholar
• GOLD Executive Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: 2019. [Internet]. Available from: www.goldcopd.org.
   Google Scholar
• O’Donnell DE, Gebke KB. Examining the role of activity, exercise, and pharmacology in mild COPD. Postgrad Med. 2014;126(5):135–145. doi:10.3810/pgm.2014.09.2808.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Gebke KB. Activity restriction in mild COPD: a challenging clinical problem. Int J Chron Obstruct Pulmon Dis. 2014;9:577–588. doi:10.2147/COPD.S62766.
   PubMed Web of Science ®Google Scholar
• James MD, Milne KM, Phillips DB, et al. Dyspnea and exercise limitation in mild COPD: the value of CPET. Front Med (Lausanne). 2020;7:442. doi:10.3389/fmed.2020.00442.
   PubMed Web of Science ®Google Scholar
• Neder JA, de Torres JP, O’Donnell DE. Recent advances in the physiological assessment of dyspneic patients with mild COPD. COPD. 2021;18(3):374–384. doi:10.1080/15412555.2021.1913110.
   PubMedGoogle Scholar
• Ofir D, Laveneziana P, Webb KA, et al. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(6):622–629. doi:10.1164/rccm.200707-1064OC.
   PubMed Web of Science ®Google Scholar
• Deesomchok A, Webb KA, Forkert L, et al. Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity. COPD. 2010;7(6):428–437. doi:10.3109/15412555.2010.528087.
   PubMedGoogle Scholar
• Guenette JA, Raghavan N, Harris-McAllister V, et al. Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD. Respir Med. 2011;105(12):1836–1845. doi:10.1016/j.rmed.2011.08.021.
   PubMed Web of Science ®Google Scholar
• Guenette JA, Webb KA, O’Donnell DE. Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD. Respir Med. 2013;107(5):708–716. doi:10.1016/j.rmed.2013.01.009.
   PubMed Web of Science ®Google Scholar
• Chin RC, Guenette JA, Cheng S, et al. Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2013;187(12):1315–1323. doi:10.1164/rccm.201211-1970OC.
   PubMed Web of Science ®Google Scholar
• Guenette JA, Chin RC, Cheng S, et al. Mechanisms of exercise intolerance in global initiative for chronic obstructive lung disease grade 1 COPD. Eur Respir J. 2014;44(5):1177–1187. doi:10.1183/09031936.00034714.
   PubMed Web of Science ®Google Scholar
• Neder JA, Arbex FF, Alencar MCN, et al. Exercise ventilatory inefficiency in mild to end-stage COPD. Eur Respir J. 2015;45(2):377–387. doi:10.1183/09031936.00135514.
   PubMed Web of Science ®Google Scholar
• Neder JA, O’Donnell CDJ, Cory J, et al. Ventilation distribution heterogeneity at rest as a marker of exercise impairment in mild-to-Advanced COPD. COPD. 2015;12(3):249–256. doi:10.3109/15412555.2014.948997.
   PubMedGoogle Scholar
• Elbehairy AF, Ciavaglia CE, Webb KA, et al. Pulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease. Implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med. 2015;191(12):1384–1394. doi:10.1164/rccm.201501-0157OC.
   PubMed Web of Science ®Google Scholar
• Elbehairy AF, Raghavan N, Cheng S, et al. Physiologic characterization of the chronic bronchitis phenotype in GOLD grade IB COPD. Chest. 2015;147(5):1235–1245. doi:10.1378/chest.14-1491.
   PubMed Web of Science ®Google Scholar
• Elbehairy AF, Guenette JA, Faisal A, et al. Mechanisms of exertional dyspnoea in symptomatic smokers without COPD. Eur Respir J. 2016;48(3):694–705. doi:10.1183/13993003.00077-2016.
   PubMed Web of Science ®Google Scholar
• Faisal A, Alghamdi BJ, Ciavaglia CE, et al. Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am J Respir Crit Care Med. 2016;193(3):299–309. doi:10.1164/rccm.201504-0841OC.
   PubMed Web of Science ®Google Scholar
• Elbehairy AF, Faisal A, Guenette JA, et al. Resting physiological correlates of reduced exercise capacity in smokers with mild airway obstruction. COPD. 2017;14(3):267–275. doi:10.1080/15412555.2017.1281901.
   PubMedGoogle Scholar
• Elbehairy AF, Parraga G, Webb KA, et al. Mild chronic obstructive pulmonary disease: why spirometry is not sufficient!. Expert Rev Respir Med. 2017;11(7):549–563. doi:10.1080/17476348.2017.1334553.
   PubMed Web of Science ®Google Scholar
• Zelt JT, Jones JH, Hirai DM, et al. Systemic vascular dysfunction is associated with emphysema burden in mild COPD. Respir Med. 2018;136:29–36. doi:10.1016/j.rmed.2018.01.007.
   PubMed Web of Science ®Google Scholar
• Phillips DB, James MD, Elbehairy AF, et al. Reduced exercise tolerance in mild chronic obstructive pulmonary disease: the contribution of combined abnormalities of diffusing capacity for carbon monoxide and ventilatory efficiency. Respirology. 2021;26(8):786–795. doi:10.1111/resp.14045.
   PubMed Web of Science ®Google Scholar
• Phillips DB, Domnik NJ, Elbehairy AF, et al. Elevated exercise ventilation in mild COPD is not linked to enhanced central chemosensitivity. Respir Physiol Neurobiol. 2021;284:103571. doi:10.1016/j.resp.2020.103571.
   PubMed Web of Science ®Google Scholar
• Phillips DB, Neder JA, Elbehairy AF, et al. Qualitative components of dyspnea during incremental exercise across the COPD continuum. Med Sci Sports Exerc. 2021;53(12):2467–2476. doi:10.1249/MSS.0000000000002741.
   PubMed Web of Science ®Google Scholar
• Neder JA, Berton DC, Phillips DB, et al. Exertional ventilation/carbon dioxide output relationship in COPD: from physiological mechanisms to clinical applications. Eur Respir Rev. 2021;30(161):200190. doi:10.1183/16000617.0190-2020.
   PubMed Web of Science ®Google Scholar
• Elbehairy AF, O’Donnell CD, Abd Elhameed A, et al. Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. J Appl Physiol (1985). 2019;127(4):1107–1116., doi:10.1152/japplphysiol.00341.2019.
   PubMed Web of Science ®Google Scholar
• Glenny RW, Robertson HT. Spatial distribution of ventilation and perfusion: mechanisms and regulation. Compr Physiol. 2011;1(1):375–395. doi:10.1002/cphy.c100002.
   PubMed Web of Science ®Google Scholar
• West JB. State of the art: ventilation-perfusion relationships. Am Rev Respir Dis. 1977;116(5):919–943. doi:10.1164/arrd.1977.116.5.919.
   PubMedGoogle Scholar
• West JB. Regional differences in gas exchange in the lung of erect man. J Appl Physiol. 1962;17(6):893–898. doi:10.1152/jappl.1962.17.6.893.
   PubMed Web of Science ®Google Scholar
• Cardús J, Burgos F, Diaz O, et al. Increase in pulmonary ventilation-perfusion inequality with age in healthy individuals. Am J Respir Crit Care Med. 1997;156(2 Pt 1):648–653. doi:10.1164/ajrccm.156.2.9606016.
   PubMed Web of Science ®Google Scholar
• Neder JA, Berton DC, Arbex FF, et al. Physiological and clinical relevance of exercise ventilatory efficiency in COPD. Eur Respir J. 2017;49(3):1602036. doi:10.1183/13993003.02036-2016.
   PubMed Web of Science ®Google Scholar
• West JB. Understanding pulmonary gas exchange: ventilation-perfusion relationships. Am J Physiol Lung Cell Mol Physiol. 2004;287(6):L1071–1072. doi:10.1152/classicessays.00024.2004.
   PubMed Web of Science ®Google Scholar
• Dempsey JA, Wagner PD. Exercise-induced arterial hypoxemia. J Appl Physiol (1985). 1999;87(6):1997–2006. doi:10.1152/jappl.1999.87.6.1997.
   PubMed Web of Science ®Google Scholar
• Wagner PD. Ventilation-perfusion matching during exercise. Chest. 1992;101(5 Suppl):192S–198S. doi:10.1378/chest.101.5_supplement.192s.
   PubMed Web of Science ®Google Scholar
• Whipp BJ, Ward SA. Cardiopulmonary coupling during exercise. J Exp Biol. 1982;100(1):175–193. doi:10.1242/jeb.100.1.175.
   PubMedGoogle Scholar
• Whipp BJ. Control of the exercise hyperpnea: the unanswered question. Adv Exp Med Biol. 2008;605:16–21. doi:10.1007/978-0-387-73693-8_3.
   PubMed Web of Science ®Google Scholar
• Riley RL, Cournand A. Ideal alveolar air and the analysis of ventilation-perfusion relationships in the lungs. J Appl Physiol. 1949;1(12):825–847. doi:10.1152/jappl.1949.1.12.825.
   PubMed Web of Science ®Google Scholar
• Agustí A, Hogg JC. Update on the pathogenesis of chronic obstructive pulmonary disease. N Engl J Med. 2019;381(13):1248–1256. doi:10.1056/NEJMra1900475.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Roisin R, Drakulovic M, Rodríguez DA, et al. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol (1985). 2009;106(6):1902–1908. doi:10.1152/japplphysiol.00085.2009.
   PubMed Web of Science ®Google Scholar
• Neder JA. Residual exertional dyspnea in cardiopulmonary disease. Ann Am Thorac Soc. 2020;17(12):1516–1525. doi:10.1513/AnnalsATS.202004-398FR.
   PubMed Web of Science ®Google Scholar
• Pain CF, Glazier JB, Simon H, et al. Regional and overall inequality of ventilation and blood flow in patients with chronic airflow obstruction. Thorax. 1967;22(5):453–461. doi:10.1136/thx.22.5.453.
   PubMed Web of Science ®Google Scholar
• West JB, Crouch DR, Fine JM, et al. A new, noninvasive method of measuring impaired pulmonary gas exchange in lung disease: an outpatient study. Chest. 2018;154(2):363–369. doi:10.1016/j.chest.2018.02.001.
   PubMed Web of Science ®Google Scholar
• Filley GF, Gregoire F, Wright GW. Alveolar and arterial oxygen tensions and the significance of the alveolar-arterial oxygen tension difference in normal men. J Clin Invest. 1954;33(4):517–529. doi:10.1172/JCI102922.
   PubMed Web of Science ®Google Scholar
• Kreit JW. Volume capnography in the intensive care unit: physiological principles, measurements, and calculations. Ann Am Thorac Soc. 2019;16(3):291–300. doi:10.1513/AnnalsATS.201807-501CME.
   PubMed Web of Science ®Google Scholar
• Krogh M. The diffusion of gases through the lungs of man. J Physiol. 1915;49(4):271–300. doi:10.1113/jphysiol.1915.sp001710.
   PubMedGoogle Scholar
• Roughton FJ, Forster RE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol. 1957;11(2):290–302. doi:10.1152/jappl.1957.11.2.290.
   PubMed Web of Science ®Google Scholar
• Hughes JM, Pride NB. In defence of the carbon monoxide transfer coefficient kco (TL/VA). Eur Respir J. 2001;17(2):168–174. doi:10.1183/09031936.01.17201680.
   PubMed Web of Science ®Google Scholar
• Stam H, Versprille A, Bogaard JM. The components of the carbon monoxide diffusing capacity in man dependent on alveolar volume. Bull Eur Physiopathol Respir. 1983;19(1):17–22.
   PubMedGoogle Scholar
• Guenard H, Varene N, Vaida P. Determination of lung capillary blood volume and membrane diffusing capacity in man by the measurements of NO and CO transfer. Respir Physiol. 1987;70(1):113–120. doi:10.1016/s0034-5687(87)80036-1.
   PubMedGoogle Scholar
• Jones NL, Robertson DG, Kane JW. Difference between end-tidal and arterial PCO2 in exercise. J Appl Physiol Respir Environ Exerc Physiol. 1979;47(5):954–960. doi:10.1152/jappl.1979.47.5.954.
   PubMed Web of Science ®Google Scholar
• Bohr C. [Ueber die Lungenathmung]. Skand Arch Physiol. 1891;2(1):236–268. doi:10.1111/j.1748-1716.1891.tb00581.x.
   Google Scholar
• Enghoff H[, I, Volumen. Bermekungen zur Frage des shadlichen Raumes. Upsala Laekarefoeren]. Foerh. 1938;14:191–218.
   Google Scholar
• Ming DKY, Patel MS, Hopkinson NS, et al. The ‘anatomic shunt test’ in clinical practice; contemporary description of test and in-service evaluation. Thorax. 2014;69(8):773–775. doi:10.1136/thoraxjnl-2013-204103.
   PubMed Web of Science ®Google Scholar
• Neder JA, Kirby M, Santyr G, et al. V̇/Q̇ mismatch: a novel target for COPD treatment. Chest. 2022;162(5):1030–1047. doi:10.1016/j.chest.2022.03.033.
   PubMed Web of Science ®Google Scholar
• Wagner PD, Dantzker DR, Dueck R, et al. Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J Clin Invest. 1977;59(2):203–216. doi:10.1172/JCI108630.
   PubMed Web of Science ®Google Scholar
• Rocha A, Arbex FF, Sperandio PA, et al. Excess ventilation in chronic obstructive pulmonary disease-Heart failure overlap. Implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med. 2017;196(10):1264–1274. doi:10.1164/rccm.201704-0675OC.
   PubMed Web of Science ®Google Scholar
• Costa CM, Neder JA, Verrastro CG, et al. Uncovering the mechanisms of exertional dyspnoea in combined pulmonary fibrosis and emphysema. Eur Respir J. 2020;55(1):1901319. doi:10.1183/13993003.01319-2019.
   PubMed Web of Science ®Google Scholar
• Neder JA, Rocha A, Arbex FF, et al. Exertional oscillatory ventilation in subjects without heart failure reporting chronic dyspnoea. ERJ Open Res. 2023;9(1):00324–2022. doi:10.1183/23120541.00324-2022.
   PubMedGoogle Scholar
• Dempsey JA, Smith CA. Pathophysiology of human ventilatory control. Eur Respir J. 2014;44(2):495–512. doi:10.1183/09031936.00048514.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Elbehairy AF, Berton DC, et al. Advances in the evaluation of respiratory pathophysiology during exercise in chronic lung diseases. Front Physiol. 2017;8:82. doi:10.3389/fphys.2017.00082.
   PubMed Web of Science ®Google Scholar
• Wasserman K, Whipp BJ, Koyl SN, et al. Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol. 1973;35(2):236–243. doi:10.1152/jappl.1973.35.2.236.
   PubMed Web of Science ®Google Scholar
• Neder JA, Berton DC, Marillier M, et al. Resting V’E/V’CO2 adds to inspiratory capacity to predict the burden of exertional dyspnoea in COPD. Eur Respir J. 2020;56(1):1902434. doi:10.1183/13993003.02434-2019.
   PubMed Web of Science ®Google Scholar
• Jones JH, Zelt JT, Hirai DM, et al. Emphysema on thoracic CT and exercise ventilatory inefficiency in mild-to-moderate COPD. COPD. 2017;14(2):210–218. doi:10.1080/15412555.2016.1253670.
   PubMedGoogle Scholar
• James MD, Phillips DB, Elbehairy AF, et al. Mechanisms of exertional dyspnea in patients with mild COPD and a low resting DLCO. COPD. 2021;18(5):501–510. doi:10.1080/15412555.2021.1932782.
   PubMedGoogle Scholar
• Robertson HT. Dead space: the physiology of wasted ventilation. Eur Respir J. 2015;45(6):1704–1716. doi:10.1183/09031936.00137614.
   PubMed Web of Science ®Google Scholar
• Neder JA, Berton DC, Nery LE, et al. A frame of reference for assessing the intensity of exertional dyspnoea during incremental cycle ergometry. Eur Respir J. 2020;56(4):2000191. doi:10.1183/13993003.00191-2020.
   PubMed Web of Science ®Google Scholar
• Dempsey JA, Vidruk EH, Mastenbrook SM. Pulmonary control systems in exercise. Fed Proc. 1980;39(5):1498–1505.
   PubMedGoogle Scholar
• Mahler DA, O’Donnell DE. Recent advances in dyspnea. Chest. 2015;147(1):232–241. doi:10.1378/chest.14-0800.
   PubMed Web of Science ®Google Scholar
• Laviolette L, Laveneziana P. Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J. 2014;43(6):1750–1762. doi:10.1183/09031936.00092613.
   PubMed Web of Science ®Google Scholar
• Berton DC, Plachi F, James MD, et al. Dynamic ventilatory reserve during incremental exercise: reference values and clinical validation in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2023;20(10):1425–1434. doi:10.1513/AnnalsATS.202304-303OC.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Milne KM, Vincent SG, et al. Unraveling the causes of unexplained dyspnea: the value of exercise testing. Clin Chest Med. 2019;40(2):471–499. doi:10.1016/j.ccm.2019.02.014.
   PubMed Web of Science ®Google Scholar
• Neder JA. Cardiopulmonary exercise testing applied to respiratory medicine: myths and facts. Respir Med. 2023;214:107249. doi:10.1016/j.rmed.2023.107249.
   PubMed Web of Science ®Google Scholar
• Macklem PT. The pathophysiology of chronic bronchitis and emphysema. Med Clin North Am. 1973;57(3):669–670. doi:10.1016/s0025-7125(16)32266-0.
   PubMed Web of Science ®Google Scholar
• Petersson J, Glenny RW. Gas exchange and ventilation-perfusion relationships in the lung. Eur Respir J. 2014;44(4):1023–1041. doi:10.1183/09031936.00037014.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Alfieri V, Silva M, et al. Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients. Respir Med. 2016;117:207–214. doi:10.1016/j.rmed.2016.06.016.
   PubMed Web of Science ®Google Scholar
• Rinaldo RF, Mondoni M, Comandini S, et al. The role of phenotype on ventilation and exercise capacity in patients affected by COPD: a retrospective study. Multidiscip Respir Med. 2020;15(1):476. doi:10.4081/mrm.2020.476.
   PubMed Web of Science ®Google Scholar
• Tanabe N, Rhee CK, Sato S, et al. Disproportionally impaired diffusion capacity relative to airflow limitation in COPD. COPD. 2020;17(6):627–634. doi:10.1080/15412555.2020.1845639.
   PubMedGoogle Scholar
• Kirby M, Owrangi A, Svenningsen S, et al. On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI. Thorax. 2013;68(8):752–759. doi:10.1136/thoraxjnl-2012-203108.
   PubMed Web of Science ®Google Scholar
• Xie C, Rong Z, Li Z, et al. Measurements of membrane diffusing capacity and pulmonary capillary blood volume in normal subjects and patients with mild emphysema. Chin Med J (Engl). 1996;109:840–847.
   PubMed Web of Science ®Google Scholar
• Barbera JA, Ramirez J, Roca J, et al. Lung structure and gas exchange in mild chronic obstructive pulmonary disease. Am Rev Respir Dis. 1990;141(4 Pt 1):895–901. doi:10.1164/ajrccm/141.4_Pt_1.895.
   PubMedGoogle Scholar
• Hirai DM, Jones JH, Zelt JT, et al. Oral N-acetylcysteine and exercise tolerance in mild chronic obstructive pulmonary disease. J Appl Physiol (1985). 2017;122(5):1351–1361. doi:10.1152/japplphysiol.00990.2016.
   PubMed Web of Science ®Google Scholar
• Kirby M, Pike D, Sin DD, et al. COPD: do imaging measurements of emphysema and airway disease explain symptoms and exercise capacity? Radiology. 2015;277(3):872–880. doi:10.1148/radiol.2015150037.
   PubMed Web of Science ®Google Scholar
• Ostridge K, Gove K, Paas KHW, et al. Using novel computed tomography analysis to describe the contribution and distribution of emphysema and small airways disease in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2019;16(8):990–997. doi:10.1513/AnnalsATS.201810-669OC.
   PubMed Web of Science ®Google Scholar
• Barberà JA, Riverola A, Roca J, et al. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;149(2 Pt 1):423–429. doi:10.1164/ajrccm.149.2.8306040.
   PubMed Web of Science ®Google Scholar
• Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med. 1978;298(23):1277–1281. doi:10.1056/NEJM197806082982303.
   PubMed Web of Science ®Google Scholar
• Santos S, Peinado VI, Ramirez J, et al. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(9):1250–1256. doi:10.1164/rccm.200210-1233OC.
   PubMed Web of Science ®Google Scholar
• Borek I, Birnhuber A, Voelkel NF, et al. The vascular perspective on acute and chronic lung disease. J Clin Invest. 2023;133(16):e170502. doi:10.1172/JCI170502.
   PubMed Web of Science ®Google Scholar
• Aaron CP, Hoffman EA, Lima JAC, et al. Pulmonary vascular volume, impaired left ventricular filling and dyspnea: the MESA lung study. PLoS ONE. 2017;12(4):e0176180. doi:10.1371/journal.pone.0176180.
   PubMed Web of Science ®Google Scholar
• Hueper K, Vogel-Claussen J, Parikh MA, et al. Pulmonary microvascular blood flow in mild chronic obstructive pulmonary disease and emphysema. The MESA COPD study. Am J Respir Crit Care Med. 2015;192(5):570–580. doi:10.1164/rccm.201411-2120OC.
   PubMed Web of Science ®Google Scholar
• Ross BA, Brotto AR, Fuhr DP, et al. The supine position improves but does not normalize the blunted pulmonary capillary blood volume response to exercise in mild COPD. J Appl Physiol (1985). 2020;128(4):925–933. doi:10.1152/japplphysiol.00890.2019.
   PubMed Web of Science ®Google Scholar
• Phillips DB, Brotto AR, Ross BA, et al. Inhaled nitric oxide improves ventilatory efficiency and exercise capacity in patients with mild COPD: a randomized-control cross-over trial. J Physiol. 2021;599(5):1665–1683. doi:10.1113/JP280913.
   PubMed Web of Science ®Google Scholar
• Tedjasaputra V, van Diepen S, Phillips DB, et al. Pulmonary capillary blood volume response to exercise is diminished in mild chronic obstructive pulmonary disease. Respir Med. 2018;145:57–65. doi:10.1016/j.rmed.2018.10.015.
   PubMed Web of Science ®Google Scholar
• Díaz AA, Pinto-Plata V, Hernández C, et al. Emphysema and DLCO predict a clinically important difference for 6MWD decline in COPD. Respir Med. 2015;109(7):882–889. doi:10.1016/j.rmed.2015.04.009.
   PubMed Web of Science ®Google Scholar
• Hughes JMB, Bates DV. Historical review: the carbon monoxide diffusing capacity (DLCO) and its membrane (DM) and red cell (Theta.Vc) components. Respir Physiol Neurobiol. 2003;138(2–3):115–142. doi:10.1016/j.resp.2003.08.004.
   PubMed Web of Science ®Google Scholar
• Elbehairy AF, Vincent SG, Phillips DB, et al. Pulmonary vascular volume by quantitative CT in dyspneic smokers with minor emphysema. COPD. 2023;20(1):135–143. doi:10.1080/15412555.2023.2169121.
   PubMedGoogle Scholar
• Hueper K, Parikh MA, Prince MR, et al. Quantitative and semiquantitative measures of regional pulmonary microvascular perfusion by magnetic resonance imaging and their relationships to global lung perfusion and lung diffusing capacity: the multiethnic study of atherosclerosis chronic obstructive pulmonary disease study. Invest Radiol. 2013;48(4):223–230. doi:10.1097/RLI.0b013e318281057d.
   PubMed Web of Science ®Google Scholar
• Pompe E, Strand M, van Rikxoort EM, et al. Five-year progression of emphysema and air trapping at CT in smokers with and those without chronic obstructive pulmonary disease: results from the COPDGene study. Radiology. 2020;295(1):218–226. doi:10.1148/radiol.2020191429.
   PubMed Web of Science ®Google Scholar
• Biederer J. MR imaging of the airways. Br J Radiol. 2023;96(1146):20220630. doi:10.1259/bjr.20220630.
   PubMed Web of Science ®Google Scholar
• Elbehairy AF, Webb KA, Laveneziana P, et al. Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD. Respir Physiol Neurobiol. 2018;252-253:64–71. doi:10.1016/j.resp.2018.03.012.
   PubMed Web of Science ®Google Scholar
• Liebow AA. Pulmonary emphysema with special reference to vascular changes. Am Rev Respir Dis. 1959;80(1, Part 2):67–93. doi:10.1164/arrd.1959.80.1P2.67.
   PubMedGoogle Scholar
• Ohno Y, Seo JB, Parraga G, et al. Pulmonary functional imaging: part 1-State-of-the-Art technical and physiologic underpinnings. Radiology. 2021;299(3):508–523. doi:10.1148/radiol.2021203711.
   PubMed Web of Science ®Google Scholar
• Gefter WB, Lee KS, Schiebler ML, et al. Pulmonary functional imaging: part 2—State-of-the-Art clinical applications and opportunities for improved patient care. Radiology. 2021;299(3):524–538. doi:10.1148/radiol.2021204033.
   PubMed Web of Science ®Google Scholar
• Kirby M, Yin Y, Tschirren J, et al. A novel method of estimating small airway disease using inspiratory-to-expiratory computed tomography. Respiration. 2017;94(4):336–345. doi:10.1159/000478865.
   PubMed Web of Science ®Google Scholar
• Guo F, Capaldi D, Kirby M, et al. Development of a pulmonary imaging biomarker pipeline for phenotyping of chronic lung disease. J Med Imaging (Bellingham). 2018;5(2):026002. doi:10.1117/1.JMI.5.2.026002.
   PubMedGoogle Scholar
• MacNeil JL, Capaldi DPI, Westcott AR, et al. Pulmonary imaging phenotypes of chronic obstructive pulmonary disease using multiparametric response maps. Radiology. 2020;295(1):227–236. doi:10.1148/radiol.2020191735.
   PubMed Web of Science ®Google Scholar
• Voskrebenzev A, Gutberlet M, Klimeš F, et al. Feasibility of quantitative regional ventilation and perfusion mapping with phase-resolved functional lung (PREFUL) MRI in healthy volunteers and COPD, CTEPH, and CF patients. Magn Reson Med. 2018;79(4):2306–2314. doi:10.1002/mrm.26893.
   PubMed Web of Science ®Google Scholar
• Kaireit TF, Voskrebenzev A, Gutberlet M, et al. Comparison of quantitative regional perfusion-weighted phase resolved functional lung (PREFUL) MRI with dynamic gadolinium-enhanced regional pulmonary perfusion MRI in COPD patients. J Magn Reson Imaging. 2019;49(4):1122–1132. doi:10.1002/jmri.26342.
   PubMed Web of Science ®Google Scholar
• Klimeš F, Voskrebenzev A, Gutberlet M, et al. Repeatability of dynamic 3D phase-resolved functional lung (PREFUL) ventilation MR imaging in patients with chronic obstructive pulmonary disease and healthy volunteers. J Magn Reson Imaging. 2021;54(2):618–629. doi:10.1002/jmri.27543.
   PubMed Web of Science ®Google Scholar
• Pöhler GH, Löffler F, Klimeš F, et al. Validation of phase-resolved functional lung (PREFUL) magnetic resonance imaging pulse wave transit time compared to echocardiography in chronic obstructive pulmonary disease. J Magn Reson Imaging. 2021;56(2):605–615. doi:10.1002/jmri.28016.
   PubMed Web of Science ®Google Scholar
• Pöhler GH, Klimeš F, Behrendt L, et al. Repeatability of phase-resolved functional lung (PREFUL)-MRI ventilation and perfusion parameters in healthy subjects and COPD patients. J Magn Reson Imaging. 2021;53(3):915–927. doi:10.1002/jmri.27385.
   PubMed Web of Science ®Google Scholar
• Neder JA, Berton DC, Muller PT, et al. Incorporating lung diffusing capacity for carbon monoxide in clinical decision making in chest medicine. Clin Chest Med. 2019;40(2):285–305. doi:10.1016/j.ccm.2019.02.005.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE. Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful? Chest. 2000;117:42S–47S.
   PubMed Web of Science ®Google Scholar
• Elbehairy AF, Webb KA, Neder JA, et al. Should mild COPD be treated? Evidence for early pharmacological intervention. Drugs. 2013;73(18):1991–2001. doi:10.1007/s40265-013-0145-9.
   PubMed Web of Science ®Google Scholar